Cognito Therapeutics Stock Price, Funding, Valuation, Revenue ...

Jul 2, 2024 · See Cognito Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Cognito Therapeutics's post-money valuation and revenue. …

CouponFollow Extension

$10
OFF

Cognito Therapeutics Company Profile 2024: Valuation, Funding ...

6 days from now

Cognito Therapeutics Valuation & Funding. Deal Type Date Amount Raised to Date Post-Val Status Stage; 3. Later Stage VC (Series C) 02-Jul-2024: $10.2M: Completed: Generating …

pitchbook.com

$227
OFF

Cognito Therapeutics - Raised $227M Funding From 6 Investors

6 days from now

Oct 29, 2024 · Cognito Therapeutics has raised a total funding of $227M over 5 rounds from 6 investors. Investors include Morningside, FoundersX Ventures and 4 others. ... How much …

tracxn.com

$7
OFF

Cognito Therapeutics: Revenue, Competitors, Alternatives

6 days from now

Cognito Therapeutics top competitors are Whole Person Health, Navigation Sciences and Northeast Alternatives and they have annual revenue of $7.5M and 72 employees. ...

growjo.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Mar 23, 2023 · Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX …

mobihealthnews.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance …

6 days from now

Mar 22, 2023 · The funding will advance Cognito’s pivotal study of its non-invasive neuromodulation device, which delivers proprietary gamma frequency light and sound …

businesswire.com

$2.25
OFF

Cognito Stock Price, Funding, Valuation, Revenue & Financial …

6 days from now

Funding, Valuation & Revenue. 3 Fundings. Cognito has raised $2.25M over 3 rounds.. Cognito's latest funding round was a Acquired for on January 20, 2022.. Cognito's latest post-money …

cbinsights.com

$50
OFF

Cognito Therapeutics Raises $50 Million For Alzheimer’s Treatment …

6 days from now

Jul 4, 2022 · June 28, 2022, STAT News, by Mario Aguilar - Cognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive …

foundersxventures.com

$50
OFF

Cognito Therapeutics Raises $50 Million For Alzheimer’s ... - STAT

6 days from now

Jun 28, 2022 · C ognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive decline.. Cognito, based in Cambridge, Mass., is …

statnews.com

$12.77
OFF

Cognition Therapeutics Stock Price Today (NASDAQ: CGTX) Quote, …

6 days from now

Cognition Therapeutics. stock was originally listed at a price of $12.77 in Oct 8, 2021. If you had invested in Cognition Therapeutics stock at $12.77 , your return over the last 3 years would …

wallstreetzen.com

FAQs about Cognito Therapeutics Stock Price, Funding, Valuation, Revenue ... Coupon?

How much money has Cognito Therapeutics raised?

Cognito Therapeutics has raised a total of $126.3M in funding over 2 rounds. Their latest funding was raised on Mar 22, 2023 from a Series B round. Cognito Therapeutics is funded by 5 investors. IAG Capital Partners and FoundersX Ventures are the most recent investors. Cognito Therapeutics has raised a total of $126.3M in funding over 2 rounds. ...

Who invested in Cognito Therapeutics?

Cognito Therapeutics has 7 investors. Alzheimer's Drug Discovery Foundation invested in Cognito Therapeutics's Series B funding round. Greffex is the developer of the GREVAX Universal Platform, which delivers vaccines in a fast, efficient and affordable manner, including nationwide production-to-delivery within weeks. ...

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

Who is Cognito Therapeutics?

Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses. Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses. ...

Does Cognito therapeutics have a target for cognitive decline?

June 28, 2022, STAT News, by Mario Aguilar - Cognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive decline. ...

Is Cognito a medical device company?

Cognito sits somewhere between a traditional medical device firm and the growing number of companies making software products intended to treat medical conditions, sometimes called digital therapeutics. ...